Successful Desensitization Protocol to Ivacaftor and a Compound of Elexacaftor/Tezacaftor/Ivacaftor in a Delayed Hypersensitivity Reaction Confirmed by Lymphocyte Transformation Test

P Mir-Ihara; L De Las Vecillas; R Heredia; A Fiandor; M González-Muñoz; E Zamarrón; C Prados; R Cabañas

doi:10.18176/jiaci.0961

Successful Desensitization Protocol to Ivacaftor and a Compound of Elexacaftor/Tezacaftor/Ivacaftor in a Delayed Hypersensitivity Reaction Confirmed by Lymphocyte Transformation Test

J Investig Allergol Clin Immunol. 2023 Nov 15:0. doi: 10.18176/jiaci.0961. Online ahead of print.

Authors

P Mir-Ihara¹, L De Las Vecillas^{1

2

3}, R Heredia¹, A Fiandor^{1

2

3}, M González-Muñoz^{2

4}, E Zamarrón^{2

5}, C Prados^{2

5}, R Cabañas^{1

2

3

6}

Affiliations

¹ Allergy Department. Hospital Universitario La Paz, Madrid, Spain.
² Hospital La Paz Institute for Health Research (IdiPAZ), Madrid, Spain.
³ PIELenRed Consortium.
⁴ Immunology Department. Hospital Universitario La Paz, Madrid, Spain.
⁵ Pulmonary Department. Hospital Universitario La Paz, Madrid, Spain.
⁶ Center for Biomedical Research Network on Rare Diseases (CIBERER U754), Madrid, Spain.

PMID: 37966860
DOI: 10.18176/jiaci.0961

No abstract available

Keywords: Cystic fibrosis; Cystic fibrosis transmembrane conductance modulators; Delayed hypersensitivity; Desensitization; Lymphocyte transformation test.